From: Expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study
 |  | N | % |
---|---|---|---|
Age (n = 54) | ≤ 35 years | 24 | 44,4 |
 | >35 years | 30 | 55,6 |
Histological type (n = 54) | NS | 26 | 48,1 |
 | MC | 24 | 44,4 |
 | LR | 3 | 5,6 |
 | NLP | 1 | 1,9 |
Therapy (n = 22) | ABVD | 20 | 91,0 |
 | ABVD+CMOPP | 1 | 4,5 |
 | ABVD+ CBVP-K | 1 | 4,5 |
Stage (n = 23) | 1 | 3 | 13,0 |
 | 2 | 6 | 26,1 |
 | 3 | 10 | 43,5 |
 | 4 | 4 | 17,4 |
Bulky (n = 23) | Yes | 2 | 8,7 |
 | No | 21 | 91,3 |
RT (n = 23) | Yes | 9 | 39,1 |
 | No | 14 | 60,9 |